Related Stories: Asia - Other, Contracts - Awards, Europe - Other, Logistics, Medical, Middle East - Other, Oceans - International, Other Corporation
On March 17/10 DLA’s Defense Supply Center Philadelphia awarded 2 contracts to Cardinal Health, a Dublin, OH-based pharmaceutical and medical products supplier, worth up to $807.1 million for drug distribution to US military medical facilities worldwide.
Under a firm-fixed-price, indefinite-quantity prime vendor contract (SPM2DX-10-D-0001), Cardinal Health will distribute drugs to medical facilities onboard US Navy ships. The contract has a 20-month base period with two 20-month option periods and a maximum value of $150 million, according to a DefenseLink announcement.
Under a requirements-type prime vendor contract (SPM2DX-10-D-0027), the company will distribute pharmaceuticals to US military medical facilities in Europe and the Pacific. That contract has a 20-month base period worth $206.4 million and two 20-month option periods, with a maximum value of $657.1 million, according to a FedBizOpps notice.
DLA also selected a small business qualifier as a secondary drug supplier to Europe and the Pacific.
DMS Pharmaceutical Group, a Park Ridge, IL-based small business qualifer, received a contract (SPM2DX-10-D-0130) worth up to $2.2 million, to serve as the secondary pharmaceutical vendor for US facilities in Europe and the Pacific.
For these contract, the European region encompasses all US military medical treatment facilities (MTFs) located on the Continent of Europe, including Turkey plus the surrounding seas and oceans as well as Oman and Bahrain. The Pacific region encompasses all MTFs located in the Pacific including Guam, Diego Garcia and the surrounding seas and oceans.
The prime pharmaceutical vendor contracts for Europe and the Pacific regions were awarded under the TRICARE Management Activity program.
